AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry
AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry (APOLLO)
National Heart Centre Singapore
8,000 participants
Oct 1, 2021
OBSERVATIONAL
Conditions
Summary
The overall aim is to build an AI driven national Platform for CT cOronary angiography for clinicaL and industriaL applicatiOns (APOLLO) for automated anonymization, reporting, Agatston scoring and plaque quantification in CAD. It is a "one-stop" platform spanning diagnosis to clinical management and prognosis, and aid in predicting pharmacotherapy response.
Eligibility
Inclusion Criteria3
- Age ≥21 years old
- Signed informed consent
- Clinically indicated for evaluation by CTCA
Exclusion Criteria10
- Individuals unable to provide informed consent
- Known complex congenital heart disease
- Planned invasive angiography for reasons other than CAD
- Non-cardiac illness with life expectancy \< 2 years
- Pregnancy
- Concomitant participation in another clinical trial in which subject is subject to investigational drug or device
- Cardiac event and/or coronary revascularization (percutaneous coronary intervention (PCI) and/or coronary artery bypass grafting (CABG) and/or valvular repair/replacement prior to CTCA
- Glomerular Filtration Rate ≤ 30mL/min
- Known allergy to iodinated contrast agent
- Contraindications to beta blockers or nitroglycerin or adenosine
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
CTCA is performed as part of routine care procedure.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05509010